Posts By: Gubba Group

Morepen Laboratories Plans To Raise Rs 350 Crore Through Securities; Board Seeks Shareholders’ Approval

As per the media reports, Morepen Laboratories in a press statement said that its board has approved to raise upto Rs 350 crore through the...

Continue Reading

Takeda partner with Biological E. to accelerate access to dengue vaccine

Takeda and Biological E. Limited (BE) has announced a strategic partnership to accelerate access to QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials (MDVs)....

Continue Reading

India pharma companies develop versions of Wegovy to get in on weight-loss windfall

Indian drugmakers aiming to grab a slice of the burgeoning weight-loss treatment sales pie, both at home and abroad, have begun developing their own versions...

Continue Reading

Is India new frontier for Coca-Cola? CEO leads massive delegation to nation

In a recent development India’s rising significance for the beverage giant, The Coca-Cola Company is sending a 220-member leadership team to the country this week,...

Continue Reading

Amul’s golden jubilee: Modi calls for making it biggest dairy firm globally

Prime Minister (PM) Narendra Modi urged stakeholders to make the Gujarat Cooperative Milk Marketing Federation (GCMMF), the apex organisation that markets products under the ‘Amul’...

Continue Reading

Efforts to protect BT cotton from pink bollworm in Rajasthan, workshops to be held in 124 gram panchayats

A district-level workshop was organized in the Collectorate Auditorium on the subject of pink bollworm control in BT cotton in Jaipur. District Collector Namrata Vrishni...

Continue Reading

IRRI and ISABU join efforts in revolutionizing rice farming by availing good quality rice seeds

The Burundi office of the International Rice Research Institute (IRRI) and the Institute of Agronomic Sciences of Burundi (ISABU) are jointly working to achieve one...

Continue Reading

Govt rejects EFTA’s data exclusivity demand to protect generic drug cos

India will continue to protect the interests of its generic drug firms and has rejected European Free Trade Association (EFTA) nations’ demand to keep “data...

Continue Reading

Viatris gets global Minimised Risk of AMR Certification

Viatris announced that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimised Risk...

Continue Reading